Average Insider

Where insiders trade, we follow

$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$75.54
Current Price
$3.40B
Market Cap
52W Low$11.85
Current$75.5497.6% above low, 2.4% below high
52W High$77.09

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00--All Sells
Sells12$7,573,703.95100,000
1 monthBuys00--All Sells
Sells324$64,513,893.61934,183
2 monthsBuys11$317,894.005,3001:380.15
Sells859$120,846,193.861,934,374
3 monthsBuys11$317,894.005,3001:452.04
Sells1484$143,700,533.032,507,330
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Apr 13, 2026
Schundler Russell
General Counsel
Sale13,692$38.37$525,362.04View Details
Apr 13, 2026
JEFFS ROGER
Director
Sale32,744$38.37$1,256,387.28View Details
Apr 10, 2026
JEFFS ROGER
Director
Sale21,433$40.12$859,876.96View Details
Apr 9, 2026
JEFFS ROGER
Director
Sale25,000$40.12$1,002,887.50View Details
Apr 9, 2026
Kaseta Michael
CFO and COO
Sale133,789$40.24$5,383,388.40View Details
78 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.5.2